The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer.

NCT04447183 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Differentiated Thyroid Cancer

Interventions

DRUG: Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH)
OTHER: radioactive iodine

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd